|
|
|
|
Although the vast majority of consultant neurologists would prescribe intravenous methylprednisolone for acute multiple sclerosis relapse at some time,the use of corticosteroids for multiple sclerosis was otherwise variable.There seemed to be little consensus about the use of oral steroids in acute relapse,the prescribing of a tapering course of oral steroids in acute relapse,the preside of a tapering course of oral steroids after intravenous mehthylprednisolone,or the utility of steroids in chronic multiple sclerosis.Variability of prescribing recommendations probably reflects a lack of clear evidence in the face of a wide range of clinical situations,variable access,and timing of access to neurologists in the acute phase of relapse and pressure on neurologist to treat in an otherwise"hopeless"situation.Large multicentered trials are needed to consider these issues. |
|